glp-1 obesity drug news today september 2025 30 Alarming rise in weight loss GLP-1 overdoses New oral GLP-1 drugs could
Description
Identification of a prolonged action molecular GLP-1R agonist for the treatment of femoral defects
Various sources were referred to in the secondary research process to identify and collect information for this study
What is most disturbing is the rise in children under the age of 5 who are now overweight or living with obesity
Treatment plans, medications, and procedures are selected based on an individuals situation and underlying health conditions
doi:10.1016/s0140-6736(25)01185-7 14.A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term
Photograph of Professor Goodman, credit: Goodman
